Nationwide Fund Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-100,534
| Closed | -$3.78M | – | 1506 |
|
|
2017
Q3 | $3.78M | Buy |
100,534
+33,734
| +51% | +$1.27M | 0.01% | 1149 |
|
|
2017
Q2 | $3.19M | Buy |
66,800
+10,610
| +19% | +$506K | 0.01% | 1228 |
|
|
2017
Q1 | $2.56M | Buy |
56,190
+33,482
| +147% | +$1.53M | 0.01% | 1297 |
|
|
2016
Q4 | $733K | Sell |
22,708
-1,108
| -5% | -$35.8K | ﹤0.01% | 1952 |
|
|
2016
Q3 | $815K | Hold |
23,816
| – | – | ﹤0.01% | 1907 |
|
|
2016
Q2 | $803K | Buy |
23,816
+224
| +0.9% | +$7.55K | ﹤0.01% | 1873 |
|
|
2016
Q1 | $1.27M | Sell |
23,592
-10,474
| -31% | -$563K | 0.01% | 1579 |
|
|
2015
Q4 | $2.62M | Sell |
34,066
-27,044
| -44% | -$2.08M | 0.01% | 1237 |
|
|
2015
Q3 | $2.51M | Buy |
61,110
+37,500
| +159% | +$1.54M | 0.01% | 1253 |
|
|
2015
Q2 | $1.67M | Sell |
23,610
-12,425
| -34% | -$879K | 0.01% | 1550 |
|
|
2015
Q1 | $3.2M | Sell |
36,035
-11,202
| -24% | -$995K | 0.01% | 1214 |
|
|
2014
Q4 | $4.19M | Sell |
47,237
-6,109
| -11% | -$542K | 0.02% | 1037 |
|
|
2014
Q3 | $5.17M | Sell |
53,346
-399
| -0.7% | -$38.7K | 0.02% | 932 |
|
|
2014
Q2 | $4.94M | Buy |
53,745
+8,076
| +18% | +$742K | 0.02% | 977 |
|
|
2014
Q1 | $3.2M | Buy |
45,669
+24,346
| +114% | +$1.7M | 0.01% | 1097 |
|
|
2013
Q4 | $1.23M | Sell |
21,323
-604
| -3% | -$34.7K | 0.01% | 1757 |
|
|
2013
Q3 | $1.05M | Buy |
21,927
+4,960
| +29% | +$238K | ﹤0.01% | 1822 |
|
|
2013
Q2 | $492K | Buy |
+16,967
| New | +$492K | ﹤0.01% | 2021 |
|